The role of p53 in metabolic regulation

Genes and Cancer

Volumn 2, Issue 4, 2011, Pages 385-391

  Puzio Kuter, Anna M ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

aerobic glycolysis; oxidative phosphorylation; oxidative stress; p53

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; FATTY ACID; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLUTAMINASE; GUANIDINOACETATE METHYLTRANSFERASE; LACTATE DEHYDROGENASE; METFORMIN; MUTANT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OXYGEN; PHOSPHOGLYCERATE MUTASE; PROTEIN P53; PUMA PROTEIN; PYRUVATE KINASE; REACTIVE OXYGEN METABOLITE;

AMINO ACID SYNTHESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; BINDING SITE; BREATHING RATE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CATABOLISM; CELL CYCLE REGULATION; CELL DEATH; CELL DISRUPTION; CELL DIVISION; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL HYPOXIA; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; ENERGY METABOLISM; ENERGY RESOURCE; ENERGY YIELD; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; GENE ACTIVATION; GENE TARGETING; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; METABOLIC REGULATION; METABOLIC STRESS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 80053036165     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911409738     Document Type: Review

References (59)

1. Warburg O.On respiratory impairment in cancer cells.Science. 1956;124 (3215): 269-70.
2. Yeung SJ,Pan J,Lee MH.Roles of p53, MYC and HIF-1 in regulating glycolysis: the seventh hallmark of cancer.Cell Mol Life Sci. 2008;65 (24): 3981-99.
3. Vousden KH,Ryan KM.p53 and metabolism.Nat Rev Cancer. 2009;9 (10): 691-700.
4. Pfeiffer T,Schuster S,Bonhoeffer S.Cooperation and competition in the evolution of ATP-producing pathways.Science. 2001;292 (5516): 504-7.
5. Christofk HR,Vander Heiden MG,Harris MH, et al.The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.Nature. 2008;452 (7184): 230-3.
6. Bensaad K,Vousden KH.p53: new roles in metabolism.Trends Cell Biol. 2007;17 (6): 286-91.
7. Schwartzenberg-Bar-Yoseph F,Armoni M,Karnieli E.The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.Cancer Res. 2004;64 (7): 2627-33.
8. Bensaad K,Tsuruta A,Selak MA, et al.TIGAR, a p53-inducible regulator of glycolysis and apoptosis.Cell. 2006;126 (1): 107-20.
9. Chipuk JE,Bouchier-Hayes L,Kuwana T,Newmeyer DD,Green DR.PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.Science. 2005;309 (5741): 1732-5.
10. Hu W,Zhang C,Wu R,Sun Y,Levine A,Feng Z.Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.Proc Natl Acad Sci U S A. 2010;107 (16): 7455-60.
11. Ide T,Brown-Endres L,Chu K, et al.GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress.Mol Cell. 2009;36 (3): 379-92.
12. Kondoh H,Lleonart ME,Gil J, et al.Glycolytic enzymes can modulate cellular life span.Cancer Res. 2005;65 (1): 177-85.
13. Matoba S,Kang JG,Patino WD, et al.p53 regulates mitochondrial respiration.Science. 2006;312 (5780): 1650-3.
14. Mihara M,Erster S,Zaika A, et al.p53 has a direct apoptogenic role at the mitochondria.Mol Cell. 2003;11 (3): 577-90.
15. Suzuki S,Tanaka T,Poyurovsky MV, et al.Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.Proc Natl Acad Sci U S A. 2010;107 (16): 7461-6.
16. Zhao Y,Coloff JL,Ferguson EC,Jacobs SR,Cui K,Rathmell JC.Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation.J Biol Chem. 2008;283 (52): 36344-53.
17. Ma W,Sung HJ,Park JY,Matoba S,Hwang PM.A pivotal role for p53: balancing aerobic respiration and glycolysis.J Bioenerg Biomembr. 2007;39 (3): 243-6.
18. Mathupala SP,Heese C,Pedersen PL.Glucose catabolism in cancer cells: the type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53.J Biol Chem. 1997;272 (36): 22776-80.
19. Shakya A,Cooksey R,Cox JE,Wang V,McClain DA,Tantin D.Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.Nat Cell Biol. 2009;11 (3): 320-7.
20. Zheng L,Roeder RG,Luo Y.S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component.Cell. 2003;114 (2): 255-66.
21. Coloff JL,Mason EF,Altman BJ, et al.AKT requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.J Biol Chem. 2011;286 (7): 5921-33.
22. Medes G,Thomas A,Weinhouse S.Metabolism of neoplastic tissue: IV. A study of lipid synthesis in neoplastic tissue slices in vitro.Cancer Res. 1953;13 (1): 27-9.
23. Fritz V,Fajas L.Metabolism and proliferation share common regulatory pathways in cancer cells.Oncogene. 2010;29 (31): 4369-77.
24. Ide T,Chu K,Aaronson SA,Lee SW.GAMT joins the p53 network: branching into metabolism.Cell Cycle. 2010;9 (9): 1706-10.
25. Wakil SJ.Fatty acid synthase, a proficient multifunctional enzyme.Biochemistry. 1989;28 (11): 4523-30.
26. D'Erchia AM,Tullo A,Lefkimmiatis K,Saccone C,Sbisa E.The fatty acid synthase gene is a conserved p53 family target from worm to human.Cell Cycle. 2006;5 (7): 750-8.
27. Buzzai M,Jones RG,Amaravadi RK, et al.Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.Cancer Res. 2007;67 (14): 6745-52.
28. Deberardinis RJ,Lum JJ,Thompson CB.Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth.J Biol Chem. 2006;281 (49): 37372-80.
29. Carling D,Zammit VA,Hardie DG.A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis.FEBS Lett. 1987;223 (2): 217-22.
30. Jones RG,Thompson CB.Tumor suppressors and cell metabolism: a recipe for cancer growth.Genes Dev. 2009;23 (5): 537-48.
31. DeBerardinis RJ,Lum JJ,Hatzivassiliou G,Thompson CB.The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.Cell Metab. 2008;7 (1): 11-20.
32. Budanov AV,Karin M.p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.Cell. 2008;134 (3): 451-60.
33. Ellisen LW,Ramsayer KD,Johannessen CM, et al.REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.Mol Cell. 2002;10 (5): 995-1005.
34. Feng Z,Hu W,de Stanchina E, et al.The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.Cancer Res. 2007;67 (7): 3043-53.
35. Feng Z,Zhang H,Levine AJ,Jin S.The coordinate regulation of the p53 and mTOR pathways in cells.Proc Natl Acad Sci U S A. 2005;102 (23): 8204-9.
36. Stambolic V,MacPherson D,Sas D, et al.Regulation of PTEN transcription by p53.Mol Cell. 2001;8 (2): 317-25.
37. Brugarolas J,Lei K,Hurley RL, et al.Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.Genes Dev. 2004;18 (23): 2893-904.
38. Feng Z,Levine AJ.The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.Trends Cell Biol. 2010;20 (7): 427-34.
39. Reuter S,Gupta SC,Chaturvedi MM,Aggarwal BB.Oxidative stress, inflammation, and cancer: how are they linked?.Free Radic Biol Med. 2010;49 (11): 1603-16.
40. Budanov AV,Sablina AA,Feinstein E,Koonin EV,Chumakov PM.Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.Science. 2004;304 (5670): 596-600.
41. Cano CE,Gommeaux J,Pietri S, et al.Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.Cancer Res. 2009;69 (1): 219-26.
42. Tan M,Li S,Swaroop M,Guan K,Oberley LW,Sun Y.Transcriptional activation of the human glutathione peroxidase promoter by p53.J Biol Chem. 1999;274 (17): 12061-6.
43. Yoon KA,Nakamura Y,Arakawa H.Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.J Hum Genet. 2004;49 (3): 134-40.
44. Chen W,Sun Z,Wang XJ, et al.Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response.Mol Cell. 2009;34 (6): 663-73.
45. Drane P,Bravard A,Bouvard V,May E.Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis.Oncogene. 2001;20 (4): 430-9.
46. Faraonio R,Vergara P,Di Marzo D, et al.p53 suppresses the Nrf2-dependent transcription of antioxidant response genes.J Biol Chem. 2006;281 (52): 39776-84.
47. Hussain SP,Amstad P,He P, et al.p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis.Cancer Res. 2004;64 (7): 2350-6.
48. Liu Z,Lu H,Shi H, et al.PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.Cancer Res. 2005;65 (5): 1647-54.
49. Polyak K,Xia Y,Zweier JL,Kinzler KW,Vogelstein B.A model for p53-induced apoptosis.Nature. 1997;389 (6648): 300-5.
50. Rivera A,Maxwell SA.The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway.J Biol Chem. 2005;280 (32): 29346-54.
51. Trinei M,Giorgio M,Cicalese A, et al.A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis.Oncogene. 2002;21 (24): 3872-8.
52. Liu B,Chen Y,St Clair DK.ROS and p53: a versatile partnership.Free Radic Biol Med. 2008;44 (8): 1529-35.
53. Ak P,Levine AJ.p53 and NF-kappaB: different strategies for responding to stress lead to a functional antagonism.FASEB J. 2010;24 (10): 3643-52.
54. Kawauchi K,Araki K,Tobiume K,Tanaka N.p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.Nat Cell Biol. 2008;10 (5): 611-8.
55. Wells L,Kreppel LK,Comer FI,Wadzinski BE,Hart GW.O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits.J Biol Chem. 2004;279 (37): 38466-70.
56. Haltiwanger RS,Holt GD,Hart GW.Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins: identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.J Biol Chem. 1990;265 (5): 2563-8.
57. Kornfeld S,Kornfeld R,Neufeld EF,O'Brien PJ.The feedback control of sugar nucleotide biosynthesis in liver.Proc Natl Acad Sci U S A. 1964;52:371-9.
58. Yang WH,Kim JE,Nam HW, et al.Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.Nat Cell Biol. 2006;8 (10): 1074-83.
59. Kawauchi K,Araki K,Tobiume K,Tanaka N.Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification.Proc Natl Acad Sci U S A. 2009;106 (9): 3431-6.